Transfection of mammalian cells using block copolypeptide vesicles

Macromol Biosci. 2013 May;13(5):539-50. doi: 10.1002/mabi.201200383. Epub 2013 Mar 4.

Abstract

An arginine-leucine block copolypeptide (R60 L20 ) is synthesized, which is capable of forming vesicles with controllable sizes, able to transport hydrophilic cargo across the cell membrane, and exhibit relatively low cytotoxicity. The R60 L20 vesicles also possess the ability to deliver DNA into mammalian cells for transfection. Although the transfection efficiency is lower than that of the commercially available transfection agent Lipofectamine 2000, the R60 L20 vesicles are able to achieve transfection with significantly lower cytotoxicity and immunogenicity. This behavior is potentially due to its stronger interaction with DNA which subsequently provides better protection against anionic heparin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Anions
  • DNA / metabolism
  • Deoxyribonuclease I / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • HeLa Cells
  • Humans
  • Interleukin-6 / metabolism
  • Light
  • Lipids
  • Luminescent Proteins / metabolism
  • Mice
  • Microscopy, Confocal
  • Peptides / pharmacology*
  • Plasmids / metabolism
  • Scattering, Radiation
  • Transfection / methods*
  • Unilamellar Liposomes / chemistry*

Substances

  • Anions
  • Interleukin-6
  • Lipids
  • Lipofectamine
  • Luminescent Proteins
  • Peptides
  • Unilamellar Liposomes
  • fluorescent protein 583
  • DNA
  • Deoxyribonuclease I